Agenus Inc. (NASDAQ:AGEN) is simply too cheap to pass with a price-to-sales ratio of 8.37. The competitors from Biotechnology hold an average P/S ratio of 96.13, which offer premium compared with the sector’s 5.42. In the past 13-year record, this ratio went down as low as 4.6 and as high as 141.76. Also, it is up from 54% of the total 706 rivals across the globe.
AGEN traded at an unexpectedly low level on 11/30/2017 when the stock experienced a 1.81% gain to a closing price of $3.93. The company saw 0.96 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 1.46 million shares a day, this signifies a pretty significant change over the norm.
Analysts are speculating a 281.68% move, based on the high target price ($15) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $11 price target, but the stock is already up 22.81% from its recent lows. However, the stock is trading at -27.89% versus recent highs ($5.45). Analysts believe that we could see stock price minimum in the $7 range (lowest target price), allowing for another 78.12% jump from its current position. Leading up to this report, we have seen a 7.38% rise in the stock price over the last 30 days and a 6.5% increase over the past 3 months. Overall, the share price is down -4.61% so far this year. Additionally, AGEN had a day price range of $3.89 to $4.02.Agenus Inc. (AGEN) Price Potential
Heading into the stock price potential, Agenus Inc. needs to grow just 179.9% to cross its median price target of $11. In order to determine directional movement, the 50-day and 200-day moving averages for Agenus Inc. (NASDAQ:AGEN) are $3.92 and $3.97. Given that liquidity is king in short-term, AGEN is a stock with 89.21 million shares outstanding that normally trades 20.07% of its float. The stock price recently experienced a 5-day loss of -2.24% with 0.21 average true range (ATR). AGEN has a beta of 2.1 and RSI is 52.64.
Investors also need to beware of the Applied Materials, Inc. (NASDAQ:AMAT) valuations. The stock trades on a P/S of 3.88, which suggests that the shares are not attractive compared with peers. The broad Semiconductor Equipment & Materials industry has an average P/S ratio of 3.78, which is significantly worse than the sector’s 2.69. In the past 13-year record, this ratio went down as low as 1.23 and as high as 4.32. Also, it is down from 79% of the total 838 rivals across the globe.Applied Materials, Inc. (AMAT)’s Lead Over its Technicals
Applied Materials, Inc. by far traveled 76.78% versus a 1-year low price of $30.06. The share price was last seen -0.26% lower, reaching at $52.77 on 11/30/2017. At recent session, the prices were hovering between $52.33 and $53.755. This company shares are 29.32% off its target price of $68.24 and the current market capitalization stands at $56.52B. The recent change has given its price a -2.78% deficit over SMA 50 and -13.34% deficit over its 52-week high. The stock witnessed -6.49% declines, 16.95% gains and 12.76% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AMAT’s volatility during a week at 3.51% and during a month it has been found around 2.83%.
Applied Materials, Inc. (AMAT) exchanged hands at an unexpectedly high level of 14.53 million shares over the course of the day. Noting its average daily volume at 10.5 million shares each day over the month, this signifies a pretty significant change over the norm.Applied Materials, Inc. Target Levels
The market experts are predicting a 51.6% rally, based on the high target price ($80) for Applied Materials, Inc. shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $43 range (lowest target price). If faced, it would be a -18.51% drop from its current position. Overall, the share price is up 63.53% year to date.